Search Within

Brian Higgins

Formats
  1. Journal Article (7)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (11)
  2. Genitourinary Oncology Service (11)
  3. Solid Tumor Oncology Division (11)
  4. Biostatistics Service (2)
  5. Epidemiology and Biostatistics (2)
  6. Breast Medicine Service (1)

More Groups

People
  1. Howard Scher (11)
  2. David Agus (10)
  3. Carlos Cordon-Cardo (8)
  4. William Fox (8)
  5. Krista Maiese (4)
  6. Marija Drobnjak (4)

More People

Years
  1. 2002 (2)
  2. 2001 (1)
  3. 2000 (6)
  4. 1999 (2)
Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (3)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (3)
  4. Cancer Cell (1)
  5. Seminars in Oncology (1)
Publishers
  1. American Association for Cancer Research (9)
  2. Cell Press (1)
  3. Elsevier Inc. (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Mùˆnster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
    Journal Article

    Agus, D. B.; Akita, R. W.; Fox, W. D.; Lewis, G. D.; Higgins, B.; Pisacane, P. I.; Lofgren, J. A.; Tindell, C.; Evans, D. P.; Maiese, K.; more...
    Cancer Cell (2002)

    Fulltext@MSK | Save
  • Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Journal Article

    Butler, L. M.; Webb, Y.; Agus, D. B.; Higgins, B.; Tolentino, T. R.; Kutko, M. C.; LaQuaglia, M. P.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Antibody to VEGF slows growth of an androgen-independent xenograft model of prostate cancer
    Meeting Abstract

    Higgins, B.; Fox, W. D.; Scher, H. I.; Maiese, K. M.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Anti-tumor activity of Apo2 ligand (TRAIL) in androgen-dependent and androgen-independent human prostate cancer xenograft models
    Meeting Abstract

    Maiese, K. M.; Scher, H. I.; Fox, W. D.; Higgins, B.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft
    Meeting Abstract

    Butler, L. M.; Higgins, B.; Fox, W. D.; Agus, D. B.; Cordon-Cardo, C.; Scher, H. I.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • A potential role for activated HER-2 in prostate cancer
    Journal Article

    Agus, D. B.; Akita, R. W.; Fox, W. D.; Lofgren, J. A.; Higgins, B.; Maiese, K.; Scher, H. I.; Sliwkowski, M. X.
    Seminars in Oncology (2000)

    Fulltext@MSK | Save
  • Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R
    Journal Article

    Amler, L. C.; Agus, D. B.; Leduc, C.; Sapinoso, M. L.; Fox, W. D.; Kern, S.; Lee, D.; Wang, V.; Leysens, M.; Higgins, B.; more...
    Cancer Research (2000)

    Fulltext@MSK | Save
  • Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Journal Article

    Butler, L. M.; Agus, D. B.; Scher, H. I.; Higgins, B.; Rose, A.; Cordon-Cardo, C.; Thaler, H. T.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Cancer Research (2000)

    Fulltext@MSK | Save
  • The use of the prostate xenograft CWR22 and its androgen independent sublines in the preclinical development of herceptin
    Meeting Abstract

    Higgins, B.; Fox, W. D.; Maiese, K.; Fazzari, M.; Scher, H. I.; Agus, D. B.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save